Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

How COVID vaccines are being divvied up around the world

Canada leads the pack in terms of doses secured per capita.
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed  Google Scholar

Vaccine developers who have already reported promising phase III trial results against COVID-19 estimate that, between them, they can make sufficient doses for more than one-third of the world’s population by the end of 2021. But many people in low-income countries might have to wait until 2023 or 2024 for vaccination, according to estimates from the Duke Global Health Innovation Center in Durham, North Carolina.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-020-03370-6

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links